# Improving DEtection of Atrial fibriLlation in Primary Care With the MyDiagnostick

Study · id `cardio:ct-nct02270151` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02270151](<https://clinicaltrials.gov/study/NCT02270151>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02270151

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It plans to enroll 16000 participants.

## Technical summary

Registry record NCT02270151. Randomized; no masking; primary purpose screening. Start 2014-11 (registry gives no type); primary completion 2016-02 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose screening
- Phase: Phase 3
- Enrolled: 16000 participants (planned count; ClinicalTrials.gov record NCT02270151, source copy `cardio:ctgov-nct02270151-2016-05-12`, retrieved 2026-10-26)
- Start date: 2014-11 (registry gives no type) (ClinicalTrials.gov record NCT02270151, source copy `cardio:ctgov-nct02270151-2016-05-12`, retrieved 2026-10-26)
- Primary completion: 2016-02 (actual) (ClinicalTrials.gov record NCT02270151, source copy `cardio:ctgov-nct02270151-2016-05-12`, retrieved 2026-10-26)
- Completion: 2016-02 (actual) (ClinicalTrials.gov record NCT02270151, source copy `cardio:ctgov-nct02270151-2016-05-12`, retrieved 2026-10-26)
- Countries: Netherlands (ClinicalTrials.gov record NCT02270151, source copy `cardio:ctgov-nct02270151-2016-05-12`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02270151-2016-05-12`, retrieved 2026-10-26)

## The registry's words

- Brief title: Improving DEtection of Atrial fibriLlation in Primary Care With the MyDiagnostick
- Acronym: IDEAL-MD
- Condition: Atrial Fibrillation
- Intervention (Device): MyDiagnostick
- Lead sponsor: UMC Utrecht
- Lead sponsor class: OTHER
- Collaborator: Boehringer Ingelheim
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as the lead sponsor: UMC Utrecht (`cardio:org-umc-utrecht`)
- Registry lists this organization as a collaborator: Boehringer Ingelheim (`cardio:boehringer-ingelheim`)

## Provenance

Content hash: 799672fec01a1bc66539a406a59f4d8d593294f1d789f0b17356a8fb284f1d43
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
